A Look At JD Health International’s Valuation After Analyst Optimism And Strong Quarterly Earnings

Simply Wall St.01-13

JD Health International (SEHK:6618) has drawn fresh attention after favorable analyst commentary coincided with quarterly results showing year-on-year revenue and profit growth, prompting investors to...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2603521028?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/4422000-choice1-main-header/1585186589176","is_english":true,"pubTime":"2026-01-13 03:21","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2603521028","market":"sg","top_or_hot":-1,"title":"A Look At JD Health International’s Valuation After Analyst Optimism And Strong Quarterly Earnings","media":"Simply Wall St.","content":"<div>\n<p>JD Health International (SEHK:6618) has drawn fresh attention after favorable analyst commentary coincided with quarterly results showing year-on-year revenue and profit growth, prompting investors to...</p>\n\n<a href=\"https://simplywall.st/stocks/hk/consumer-retailing/hkg-6618/jd-health-international-shares/news/a-look-at-jd-health-internationals-valuation-after-analyst-o\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>A Look At JD Health International’s Valuation After Analyst Optimism And Strong Quarterly Earnings</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nA Look At JD Health International’s Valuation After Analyst Optimism And Strong Quarterly Earnings\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-01-13 03:21 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/hk/consumer-retailing/hkg-6618/jd-health-international-shares/news/a-look-at-jd-health-internationals-valuation-after-analyst-o><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>JD Health International (SEHK:6618) has drawn fresh attention after favorable analyst commentary coincided with quarterly results showing year-on-year revenue and profit growth, prompting investors to...</p>\n\n<a href=\"https://simplywall.st/stocks/hk/consumer-retailing/hkg-6618/jd-health-international-shares/news/a-look-at-jd-health-internationals-valuation-after-analyst-o\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0106959298.USD","symbol_name":"UBS (LUX) EQUITY FUND - EMERGING MARKETS SUSTAINABLE LEADERS (USD) \"P\" (USD) ACC","start_time":0,"source_url":"https://simplywall.st/stocks/hk/consumer-retailing/hkg-6618/jd-health-international-shares/news/a-look-at-jd-health-internationals-valuation-after-analyst-o","article_id":"2603521028","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/4422000-choice1-main-header/1585186589176"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/consumer-retailing/hkg-6618/jd-health-international-shares/news/a-look-at-jd-health-internationals-valuation-after-analyst-o","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2603521028","pubTimestamp":1768245690,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"JD Health International (SEHK:6618) has drawn fresh attention after favorable analyst commentary coincided with quarterly results showing year-on-year revenue and profit growth, prompting investors to reassess the online healthcare platform’s recent share performance.\nSee our latest analysis for JD Health International.\nThe recent 5.01% 1 day share price return and 15.21% 7 day share price return suggest momentum has picked up again, although the 143.38% 1 year total shareholder return...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"86618":"京东健康-R","LU0106959298.USD":"UBS (LUX) EQUITY FUND - EMERGING MARKETS SUSTAINABLE LEADERS (USD) \"P\" (USD) ACC","LU0463099449.HKD":"SCHRODER ISF CHINA OPPORTUNITIES \"A\" (HKD) ACC","BK4220":"综合零售","BK1591":"就地过年概念","BK4524":"宅经济概念","BK1615":"港股-互联网","BK1142":"互联网与直销零售","BK4531":"中概回港概念","BK4526":"热门中概股","HK0000320264.USD":"TAIKANG KAITAI CHINA NEW OPPORTUNITIES FUND \"A\" (USD) ACC","BK1515":"抗疫概念","BK4585":"ETF&股票定投概念","LU0307460666.USD":"EASTSPRING INVESTMENTS CHINA EQUITY \"A\" ACC","HK0000306685.HKD":"TAIKANG KAITAI CHINA NEW OPPORTUNITIES FUND \"A\" (HKD) INC","BK4503":"景林资产持仓","BK1247":"药品零售","BK4122":"互联网与直销零售","BK1571":"互联网医疗","IE00BGV7N243.SGD":"FSSA Global Emerging Markets Focus I Acc SGD","LU0588546209.SGD":"Eastspring Investments - China Equity Fund AS SGD","BK1583":"高瓴概念","LU1188198961.HKD":"SCHRODER ISF CHINA OPPORTUNITIES \"A\" (HKD) INC QV","BK4558":"双十一","LU1880383366.USD":"东方汇理中国股票基金 A2 (C)","LU0244354667.USD":"SCHRODER ISF CHINA OPPORTUNITIES \"A\" ACC","BK4509":"腾讯概念","BK4505":"高瓴资本持仓","LU0051755006.USD":"摩根大通中国A (dist)","LU1688375341.USD":"贝莱德中国灵活股票基金","SG9999002463.SGD":"LionGlobal China Growth SGD","IE0008368742.USD":"首域中国增长基金I Acc","BK4504":"桥水持仓","LU0326950275.SGD":"Schroder ISF China Opportunities A Acc SGD-H","LU0456827905.SGD":"JPMorgan Funds - China A (acc) SGD","HK0000306701.USD":"TAIKANG KAITAI CHINA NEW OPPORTUNITIES FUND \"A\" (USD) INC","BK4614":"Manus概念股","BK1589":"北水核心资产","BK4579":"人工智能","BK4588":"碎股","06618":"京东健康","SGXZ86797644.SGD":"MAYBANK ASIAN GROWTH AND INCOME-I \"A\" (SGDHDG) INC","SGXZ62798434.SGD":"MAYBANK ASIAN GROWTH AND INCOME-I \"A\" (SGDHDG) ACC","BK4551":"寇图资本持仓","HK0000320223.HKD":"TAIKANG KAITAI CHINA NEW OPPORTUNITIES FUND \"A\" (HKD) ACC"},"translate_title":"分析师乐观和强劲的季度盈利后京东健康国际的估值一览","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"86618":0.6,"06618":1.97},"content_text":"JD Health International (SEHK:6618) has drawn fresh attention after favorable analyst commentary coincided with quarterly results showing year-on-year revenue and profit growth, prompting investors to reassess the online healthcare platform’s recent share performance. See our latest analysis for JD Health International. The recent 5.01% 1 day share price return and 15.21% 7 day share price return suggest momentum has picked up again, although the 143.38% 1 year total shareholder return contrasts with flat 3 year and weaker 5 year total shareholder returns. This hints at a story that is still rebuilding rather than fully reset. If JD Health’s move has you looking across the sector, this could be a useful moment to scan other healthcare stocks that might fit a similar online or services driven healthcare theme. With JD Health trading at HK$67.05 alongside an intrinsic value estimate and analyst targets that sit higher, the real question is whether this signals an undervalued online healthcare platform or a market that is already pricing in future growth. AdvertisementMost Popular Narrative: 12.7% Undervalued With JD Health last closing at HK$67.05 against a narrative fair value of about HK$76.81, the gap comes down to growth, margins and future earnings multiples.  Analysts are assuming JD Health International's revenue will grow by 14.7% annually over the next 3 years. In order for the above numbers to justify the analysts price target, the company would need to trade at a PE ratio of 34.4x on those 2028 earnings, down from 39.6x today.  Read the complete narrative. Curious how steady revenue growth, modest margin shifts and a premium future P/E all tie together into that higher fair value estimate? The full narrative lays out the earnings path, the expected share count changes and the discount rate that hold this valuation story together. Result: Fair Value of HK$76.81 (UNDERVALUED) Have a read of the narrative in full and understand what's behind the forecasts. However, this narrative could be shaken if competition squeezes margins or if heavier AI and omnichannel investment does not convert into the expected earnings profile. Find out about the key risks to this JD Health International narrative. Another View: What The P/E Ratio Is Telling You While the fair value narrative points to JD Health looking undervalued, the current 40.8x P/E tells a more mixed story. It sits well above the Asian Consumer Retailing average of 17x and the 21.5x fair ratio, yet below peers at 76.2x. This suggests both potential upside and valuation risk tied to expectations staying high. See what the numbers say about this price — find out in our valuation breakdown. SEHK:6618 P/E Ratio as at Jan 2026 Build Your Own JD Health International Narrative If you see the numbers differently or prefer to test your own assumptions, you can build a custom JD Health view in minutes with Do it your way. A good starting point is our analysis highlighting 3 key rewards investors are optimistic about regarding JD Health International. Looking for more investment ideas? If JD Health has sharpened your interest, do not stop here. This is your chance to broaden your watchlist with a few focused stock idea shortlists.  Spot potential value opportunities early by scanning these 885 undervalued stocks based on cash flows that the market might be pricing differently to their underlying cash flows. Ride major technology shifts by checking out these 26 AI penny stocks shaping how artificial intelligence filters into real businesses. Boost your income focus by reviewing these 12 dividend stocks with yields > 3% that combine yield above 3% with listed fundamentals.   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2603521028","isCrawlerRequest":true}